These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2467091)

  • 21. Comparison of nicardipine and propranolol in the treatment of mild and moderate hypertension.
    Naukkarinen VA; Karppinen K; Sarna S
    Eur J Clin Pharmacol; 1987; 33(2):119-26. PubMed ID: 3319640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A placebo-controlled crossover study of ketanserin in elderly hypertensive patients.
    McCarthy ST; McCarthy GL; John SM; Gould SE
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():115-7. PubMed ID: 2285640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.
    JAMA; 1982 Oct; 248(16):2004-11. PubMed ID: 6750167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketanserin in essential hypertension: use as monotherapy and in combination with a diuretic or beta-adrenoceptor antagonist.
    Cameron HA; Waller PC; Ramsay LE
    Br J Clin Pharmacol; 1987 Dec; 24(6):705-11. PubMed ID: 2894215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension.
    Wilkinson PR; Raftery EB
    Br J Clin Pharmacol; 1977 Jun; 4(3):289-94. PubMed ID: 332218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controlled trial of ketanserin in hypertension.
    McGourty JC; Silas JH; Cowen KJ
    Br J Clin Pharmacol; 1985 Jul; 20(1):37-40. PubMed ID: 3161531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of ketanserin with placebo in patients with essential hypertension.
    Wellens D; Peeters G; Baeten B; Sieben G; Symoens J
    Angiology; 1986 Nov; 37(11):810-7. PubMed ID: 3538945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter study with ketanserin in essential hypertension: an Argentine experiment.
    Demartini A; Pezzano R; Bernardiner E; Torres J; Genta C; Scheijgrond H; Gypen L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S135-7. PubMed ID: 2446062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].
    Beretta-Piccoli C; Amstein R; Bühler FR; Bertel O; Brunner HR; Follath F; Reutter F; Vallotton MB
    Schweiz Med Wochenschr; 1989 Mar; 119(12):399-406. PubMed ID: 2711155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical investigation of the effect of ketanserin: a new antihypertensive drug.
    Coto V; Oliviero U; Cocozza M; Lucariello A; Picano T; Coto F; Cacciatore L
    Drugs Exp Clin Res; 1989; 15(5):231-4. PubMed ID: 2676440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure patterns in pregnant patients on oral ketanserin.
    Steyn DW; Odendaal HJ
    Cardiovasc J S Afr; 2001; 12(2):82-7. PubMed ID: 11447496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive response to ketanserin: influence of race and weight.
    Kosoglou T; Cressman MD; Vlasses PH; Rocci ML; Gabos C; Ferguson RK
    J Clin Pharmacol; 1988 Nov; 28(11):1017-22. PubMed ID: 3072347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isotonic and isometric responses of blood pressure and heart rate in mild to moderate hypertension with isradipine and propranolol.
    Cantor A; Cristal N
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S76-8. PubMed ID: 1695309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparative study of ketanserin with atenolol in essential hypertension.
    Antonicelli R; Andreoni A; Saccomanno G; Gambini C; Paciaroni E
    Drugs Exp Clin Res; 1989; 15(11-12):577-81. PubMed ID: 2700320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketanserin in the treatment of hypertension: a multicentre dose-finding study in China.
    Liu GS; Huang DX; Yang XS; Wang SR; Tang XL; Xing JL; Peng SY; Tong YZ
    Clin Exp Hypertens A; 1991; 13(4):541-55. PubMed ID: 1934538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic and hemodynamic effects of antihypertensive treatment with ketanserin.
    Levinson PD; Zimlichman R; Goldstein DS; Brewer HB; Keiser HR
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):245S-248S. PubMed ID: 3415801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.